poisar

Stocks · News reference

Earnings Scheduled For September 17, 2026

Benzinga Insights

Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its second quarter. • Innate Pharma (NASDAQ:IPHA) is projected to report quarterly loss at $0.16 per share on revenue of $9.10

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

IPHAUPXIYI
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  2. Benzinga Insights

    Innate Pharma H1 2026 Earnings Call Transcript

    Innate Pharma (NASDAQ:IPHA) held its quarterly earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and

    IPHA
  4. Benzinga Insights

    Full Transcript: Upexi Q4 2026 Earnings Call

    Upexi (NASDAQ:UPXI) released fourth-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and

    UPXI
  5. SEC EDGAR

    8-K filing — UPEXI, INC. (UPXI)

    Filed: 2026-09-17 AccNo: 0001477932-26-005669 Size: 253 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

    UPXI